Stryker ROA 2010-2025 | SYK

Current and historical return on assets (ROA) values for Stryker (SYK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Stryker ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $2.86B $46.01B 6.65%
2024-12-31 $2.99B $42.97B 7.24%
2024-09-30 $3.59B $43.83B 8.85%
2024-06-30 $3.45B $39.13B 8.81%
2024-03-31 $3.36B $39.40B 8.69%
2023-12-31 $3.17B $39.91B 8.32%
2023-09-30 $2.59B $38.04B 6.93%
2023-06-30 $2.71B $37.41B 7.37%
2023-03-31 $2.63B $36.83B 7.21%
2022-12-31 $2.36B $36.88B 6.50%
2022-09-30 $2.46B $35.98B 6.88%
2022-06-30 $2.08B $36.03B 5.90%
2022-03-31 $2.02B $36.14B 5.81%
2021-12-31 $1.99B $34.63B 5.87%
2021-09-30 $1.90B $34.15B 5.60%
2021-06-30 $2.08B $33.70B 6.23%
2021-03-31 $1.41B $33.46B 4.28%
2020-12-31 $1.60B $34.33B 5.01%
2020-09-30 $1.76B $32.29B 5.69%
2020-06-30 $1.60B $31.48B 5.44%
2020-03-31 $2.16B $29.44B 7.69%
2019-12-31 $2.08B $30.17B 7.64%
2019-09-30 $3.43B $26.66B 12.91%
2019-06-30 $3.55B $26.35B 13.98%
2019-03-31 $3.52B $25.94B 14.55%
2018-12-31 $3.55B $27.23B 15.28%
2018-09-30 $1.24B $22.08B 5.62%
2018-06-30 $1.08B $21.57B 4.94%
2018-03-31 $1.02B $22.13B 4.68%
2017-12-31 $1.02B $22.20B 4.77%
2017-09-30 $1.78B $21.49B 8.50%
2017-06-30 $1.70B $21.29B 8.25%
2017-03-31 $1.69B $20.52B 8.27%
2016-12-31 $1.65B $20.44B 8.15%
2016-09-30 $1.66B $20.19B 8.66%
2016-06-30 $1.61B $20.52B 8.88%
2016-03-31 $1.62B $19.67B 9.42%
2015-12-31 $1.44B $16.22B 8.78%
2015-09-30 $1.18B $15.92B 7.07%
2015-06-30 $0.93B $16.82B 5.47%
2015-03-31 $0.67B $16.58B 3.90%
2014-12-31 $0.52B $17.28B 3.02%
2014-09-30 $0.64B $17.52B 3.85%
2014-06-30 $0.69B $17.23B 4.29%
2014-03-31 $0.77B $16.16B 5.05%
2013-12-31 $1.01B $15.74B 6.81%
2013-09-30 $0.89B $14.88B 6.29%
2013-06-30 $1.14B $14.38B 8.37%
2013-03-31 $1.25B $14.09B 9.57%
2012-12-31 $1.30B $13.21B 10.24%
2012-09-30 $1.43B $12.78B 11.51%
2012-06-30 $1.40B $12.26B 11.46%
2012-03-31 $1.39B $12.46B 11.50%
2011-12-31 $1.35B $12.15B 11.43%
2011-09-30 $1.24B $12.08B 10.82%
2011-06-30 $1.25B $11.60B 11.23%
2011-03-31 $1.26B $11.23B 11.71%
2010-12-31 $1.27B $10.90B 12.17%
2010-09-30 $1.28B $10.77B 12.84%
2010-06-30 $1.18B $10.06B 12.48%
2010-03-31 $1.15B $10.10B 12.92%
2009-12-31 $1.11B $9.07B 13.40%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $144.721B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.851B 27.88
Boston Scientific (BSX) United States $151.436B 37.91
EssilorLuxottica (ESLOY) France $129.653B 0.00
Medtronic (MDT) Ireland $110.247B 15.63
Lonza Group Ag (LZAGY) Switzerland $50.183B 0.00
Haleon (HLN) United Kingdom $47.171B 26.90
ResMed (RMD) United States $37.320B 28.03
Agilent Technologies (A) United States $32.988B 21.51
GE HealthCare Technologies (GEHC) United States $32.583B 15.47
Terumo (TRUMY) Japan $26.976B 35.04
Koninklijke Philips (PHG) Netherlands $21.839B 15.32
Insulet (PODD) United States $21.652B 84.99
Zimmer Biomet Holdings (ZBH) United States $18.103B 11.63
Baxter (BAX) United States $15.390B 11.49
Smith & Nephew SNATS (SNN) United Kingdom $12.776B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.410B 22.31
Lantheus Holdings (LNTH) United States $5.591B 14.10
Prestige Consumer Healthcare (PBH) United States $4.170B 18.63
Perrigo (PRGO) Ireland $3.636B 9.22
Haemonetics (HAE) United States $3.462B 15.77
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.203B 26.62
ICU Medical (ICUI) United States $3.152B 23.24
GN Store Nord (GNNDY) Denmark $2.272B 18.82
LeMaitre Vascular (LMAT) United States $1.884B 42.11
QuidelOrtho (QDEL) United States $1.870B 12.86
AtriCure (ATRC) United States $1.579B 0.00
Acuren (TIC) United States $1.283B 0.00
AdaptHealth (AHCO) United States $1.120B 11.37
Neogen (NEOG) United States $1.035B 13.25
Green Thumb Industries (GTBIF) United States $1.018B 22.91
BioLife Solutions (BLFS) United States $1.015B 0.00
Phibro Animal Health (PAHC) United States $0.991B 12.67
InMode (INMD) Israel $0.853B 8.59
Kestra Medical Technologies (KMTS) United States $0.822B 0.00
CeriBell (CBLL) United States $0.668B 0.00
Evolus (EOLS) United States $0.605B 0.00
Owens & Minor (OMI) United States $0.562B 4.67
Maravai LifeSciences Holdings (MRVI) United States $0.537B 0.00
Curaleaf Holdings (CURLF) Canada $0.514B 0.00
Valneva SE (VALN) France $0.476B 0.00
Surmodics (SRDX) United States $0.415B 0.00
Tilray Brands (TLRY) Canada $0.363B 0.00
Capricor Therapeutics (CAPR) United States $0.351B 0.00
SNDL (SNDL) Canada $0.326B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.86
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.287B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.23
Cerus (CERS) United States $0.256B 0.00
Sanara MedTech (SMTI) United States $0.247B 0.00
Quanterix (QTRX) United States $0.245B 0.00
ZimVie (ZIMV) United States $0.241B 10.95
OraSure Technologies (OSUR) United States $0.227B 0.00
Cresco Labs (CRLBF) United States $0.222B 0.00
Aurora Cannabis (ACB) Canada $0.220B 65.17
Biote (BTMD) United States $0.219B 6.17
Canopy Growth (CGC) Canada $0.219B 0.00
Brainsway (BWAY) Israel $0.217B 57.45
TriSalus Life Sciences (TLSI) United States $0.200B 0.00
Omeros (OMER) United States $0.187B 0.00
Utah Medical Products (UTMD) United States $0.178B 14.52
Verano Holdings (VRNOF) United States $0.177B 0.00
High Tide (HITI) Canada $0.175B 0.00
Organigram Global (OGI) Canada $0.171B 0.00
Exagen (XGN) United States $0.148B 0.00
Vireo Growth (VREOF) United States $0.131B 0.00
FitLife Brands (FTLF) United States $0.122B 15.02
Jin Medical (ZJYL) China $0.101B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.088B 11.29
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.084B 0.00
MacroGenics (MGNX) United States $0.083B 0.00
Cytosorbents (CTSO) United States $0.079B 0.00
Apyx Medical (APYX) United States $0.076B 0.00
TerrAscend (TSNDF) Canada $0.076B 0.00
Zynex (ZYXI) United States $0.072B 0.00
InterCure (INCR) Israel $0.071B 0.00
Agape ATP (ATPC) $0.069B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Nephros (NEPH) United States $0.045B 61.29
Modular Medical (MODD) United States $0.042B 0.00
United-Guardian (UG) United States $0.038B 13.03
Rockwell Medical (RMTI) United States $0.030B 0.00
Safety Shot (SHOT) United States $0.025B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00